Publikationen von Matthias L. Schroeter

Klöppel, S.; Boldt, J.; Sturma, D.; Schroeter, M. L.: Frühdiagnostik neurodegenerativer Erkrankungen - Nur mit umfassender Beratung [Early diagnosis of neurodegenerative diseases – Only after comprehensive counselling]. Deutsches Ärzteblatt 113 (29-30), S. B1161 - B1164 (2016)

Werner, P.; Rullmann, M.; Bresch, A.; Tiepolt, S.; Jochimsen, T.; Lobsien, D.; Schroeter, M. L.; Sabri, O.; Barthel, H.: Impact of attenuation correction on clinical [¹⁸F]FDG brain PET in combined PET/MRI. EJNMMI Research 6, 47 (2016)

Bisenius, S.; Neumann, J.; Schroeter, M. L.: Validating new diagnostic imaging criteria for primary progressive aphasia via anatomical likelihood estimation meta-analyses. European Journal of Neurology 23 (4), S. 704 - 712 (2016)

Kharabian, S.; Arélin, K.; Horstmann, A.; Lampe, L.; Kipping, J.; Luck, T.; Riedel-Heller, S.; Schroeter, M. L.; Stumvoll, M.; Villringer, A. et al.; Witte, V.: Higher body mass index in older adults is associated with lower gray matter volume: Implications for memory performance. Neurobiology of Aging 40, S. 1 - 10 (2016)

Milleit, B.; Smesny, S.; Rothermundt, M.; Preul, C.; Schroeter, M. L.; von Eiff, C.; Ponath, G.; Milleit, C.; Sauer, H.; Gaser, C.: Serum S100B protein is specifically related to white matter changes in schizophrenia. Frontiers in Cellular Neuroscience 10, 33 (2016)

Schümberg, K.; Polyakova, M.; Steiner, J.; Schroeter, M. L.: Serum S100B is related to illness duration and clinical symptoms in schizophrenia: A meta-regression analysis. Frontiers in Cellular Neuroscience 10, 46 (2016)

Mueller, K.; Arélin, K.; Möller, H. E.; Sacher, J.; Kratzsch, J.; Luck, T.; Riedel-Heller, S.; Villringer, A.; Schroeter, M. L.: Serum BDNF correlates with connectivity in the (pre)motor hub in the aging human brain: A resting-state fMRI pilot study. Neurobiology of Aging 38, S. 181 - 187 (2016)

Rullmann, M.; Dukart, J.; Hoffmann, K.-T.; Luthardt, J.; Tiepolt, S.; Patt, M.; Gertz, H.-J.; Schroeter, M. L.; Seibyl, J.; Schulz-Schaeffer, W. J. et al.; Sabri, O.; Barthel, H.: Partial-volume effect correction improves quantitative analysis of ¹⁸F-florbetaben β-amyloid PET scans. Journal of Nuclear Medicine 57 (2), S. 198 - 203 (2016)

Wessel, J. R.; Ullsperger, M.; Obrig, H.; Villringer, A.; Quinque, E. M.; Schroeter, M. L.; Bretschneider, K. J.; Arélin, K.; Roggenhofer, E.; Frisch, S. et al.; Klein, T. A.: Neural synchrony indexes impaired motor slowing after errors and novelty following white matter damage. Neurobiology of Aging 38, S. 205 - 213 (2016)

Bisenius, S.; Trapp, S.; Neumann, J.; Schroeter, M. L.: Identifying neural correlates of visual consciousness with ALE meta-analyses. NeuroImage 122, S. 177 - 187 (2015)

Polyakova, M.; Schroeter, M. L.; Elzinga, B. M.; Holiga, Š.; Schoenknecht, P.; de Kloet, E. R.; Molendijk, M. L.: Brain-derived neurotrophic factor and antidepressive effect of electroconvulsive therapy: Systematic review and meta-analyses of the preclinical and clinical literature. PLoS One 10 (11), e0141564 (2015)

Polyakova, M.; Sander, C.; Arélin, K.; Lampe, L.; Luck, T.; Luppa, M.; Kratzsch, J.; Hoffmann, K.-T.; Riedel-Heller, S.; Villringer, A. et al.; Schoenknecht, P.; Schroeter, M. L.: First evidence for glial pathology in late life minor depression: S100B is increased in males with minor depression. Frontiers in Cellular Neuroscience 9, 406 (2015)

Schroeter, M. L.; Tiepolt, S.; Marschhauser, A.; Thöne-Otto, A.; Hoffmann, K.-T.; Barthel, H.; Obrig, H.; Sabri, O.: Dissociation of amyloid biomarkers in PET and CSF in Alzheimer’s disease: A case report. BMC Neurology 15, 152 (2015)

Holiga, Š.; Mueller, K.; Möller, H. E.; Urgosik, D.; Ruzicka, E.; Schroeter, M. L.; Jech, R.: Resting-state functional magnetic resonance imaging of the subthalamic microlesion and stimulation effects in Parkinson's disease: Indications of a principal role of the brainstem. NeuroImage: Clinical 9, S. 264 - 274 (2015)

Schroeter, M. L.; Mueller, K.; Arélin, K.; Sacher, J.; Holiga, Š.; Kratzsch, J.; Luck, T.; Riedel-Heller, S.; Villringer, A.: Serum neuron-specific enolase is related to cerebellar connectivity: A resting-state functional magnetic resonance imaging pilot study. Journal of Neurotrauma 32 (17), S. 1380 - 1384 (2015)

Mueller, K.; Fritz, T. H.; Mildner, T.; Richter, M.; Schulze, K.; Lepsien, J.; Schroeter, M. L.; Möller, H. E.: Investigating the dynamics of the brain response to music: A central role of the ventral striatum/nucleus accumbens. NeuroImage 116, S. 68 - 79 (2015)

Schroeter, M. L.; Bzdok, D.; Eickhoff, S. B.; Neumann, J.: Frontomedian cortex is central for moral deficits in behavioural variant frontotemporal dementia. Journal of Neurology, Neurosurgery & Psychiatry 86 (6), S. 700 - 701 (2015)

Barthel, H.; Schroeter, M. L.; Hoffmann, K.-T.; Sabri, O.: PET/MR in dementia and other neurodegenerative diseases. Seminars in Nuclear Medicine 45 (3), S. 224 - 233 (2015)

Luck, T.; Then, F. S.; Luppa, M.; Schroeter, M. L.; Arélin, K.; Burkhardt, R.; Thiery, J.; Löffler, M.; Villringer, A.; Riedel-Heller, S. G.: Association of the apolipoprotein E genotype with memory performance and executive functioning in cognitively intact elderly. Neuropsychology 29 (3), S. 382 - 387 (2015)

Polyakova, M.; Stuke, K.; Schümberg, K.; Mueller, K.; Schoenknecht, P.; Schroeter, M. L.: BDNF as a biomarker for successful treatment of mood disorders: A systematic & quantitative meta-analysis. Journal of Affective Disorders 174, S. 432 - 440 (2015)